The Discounted Cash Flow (DCF) valuation of Carl Zeiss Meditec AG (AFX.DE) is 31.52 EUR. With the latest stock price at 53.60 EUR, the upside of Carl Zeiss Meditec AG based on DCF is -41.2%.
Based on the latest price of 53.60 EUR and our DCF valuation, Carl Zeiss Meditec AG (AFX.DE) is a sell. selling AFX.DE stocks now will result in a potential gain of 41.2%.
Range | Selected | |
WACC / Discount Rate | 5.9% - 8.5% | 7.2% |
Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
Fair Price | 18.78 - 75.52 | 31.52 |
Upside | -65.0% - 40.9% | -41.2% |